<DOC>
	<DOCNO>NCT01631773</DOCNO>
	<brief_summary>We hypothesize miRNA expression subject nasal polyps Aspirin-exacerbated respiratory disease ( AERD ) differs miRNA express subject nasal polyp without Aspirin-exacerbated respiratory disease ( AERD ) .</brief_summary>
	<brief_title>A Comparison microRNA Samples Patients With Nasal Polyps Aspirin Exacerbated Respiratory Disease Those With Nasal Polyps Only</brief_title>
	<detailed_description>Nasal epithelial tissue collect inferior nasal turbinate ten subject nasal polyp AERD disease inferior turbinate ten subject nasal polyp without AERD . A rhinoprobeâ„¢ use collect epithelial tissue . These sample analyze miRNA assay determine difference mircroRNA expression two subject group .</detailed_description>
	<mesh_term>Polyps</mesh_term>
	<mesh_term>Respiration Disorders</mesh_term>
	<mesh_term>Respiratory Tract Diseases</mesh_term>
	<mesh_term>Nasal Polyps</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Ages eligible study : 18 70 year Genders eligible study : male female Signed date write informed consent obtain prior study Subjects physician diagnosis nasal polyp without AERD physician diagnosis nasal polyp AERD . The diagnosis aspirin sensitive asthma must present minimum three month . If medical history indeterminate either aspirin challenge require confirm rule diagnosis . An aspirin challenge protocol safely perform patient procedure close supervision . Pregnant and/or lactate female . Current tobacco use . Severe psychiatric illness . Current illicit substance use dependence and/or abuse alcohol . Primary secondary immunodeficiency . Any clinically significant uncontrolled medical condition would put patient risk .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Aspirin-exacerbated respiratory disease</keyword>
	<keyword>Nasal polyp</keyword>
</DOC>